Dr. Stirewalt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000
Education & Training
University of WashingtonFellowship, Medical Oncology, 1995 - 1999
University of North Carolina at Chapel Hill School of MedicineClass of 1992, MD
Certifications & Licensure
WA State Medical License 1996 - 2025
NC State Medical License 1995 - 1998- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia Start of enrollment: 2008 Nov 01
- S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 6082 citationsCirculating microRNAs as stable blood-based markers for cancer detectionPatrick S. Mitchell, Rachael K. Parkin, Evan M. Kroh, Brian R. Fritz, Stacia K. Wyman
Proceedings of the National Academy of Sciences of the United States of America. 2008-07-29 - 91 citationsBlockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 studySteven M. Kornblau, Deborah E. Banker, Derek L. Stirewalt, Danny D. Shen, Elizabeth Lemker
Blood. 2005-11-16 - 2499 citationsArgonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaJason D. Arroyo, John R. Chevillet, Evan M. Kroh, Ingrid K. Ruf, Colin C. Pritchard
Proceedings of the National Academy of Sciences of the United States of America. 2011-03-22
Journal Articles
- Second Cycle Remission Achievement with 7+3 and Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG TrialsBrent L Wood, Roland B Walter, John E Godwin, James K Weick, Elihu H Estey, Derek L Stirewalt, Frederick R Appelbaum, Nature
Grant Support
- Discovery And Optimization Of AML Prognostic BiomarkersNational Cancer Institute2012
- IRF8 As A Biomarker Of Aging, Malignant Transformation, And AML PrognosisNational Cancer Institute2010–2011
- Quantitative Rt/Pcr-Based Radiation DosimetryNational Institute Of Allergy And Infectious Diseases2005–2009
- Examination Of FLT3 Mutations In Acute Myeloid LeukemiaNational Cancer Institute2002–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
